v>EPA
                                 United States
                                 Environmental Protection
                                 Agency
                                Health Effects Research
                                Laboratory
                                Research Triangle Park IMC 27711
                                 Research and Development
                                 EPA-600/S1-81-046 July 1981
Project  Summary
                                Improved Scoring  of Chemical
                                Transformation  of
                                C3H/10T1/2  Cells
                                Charles Heidelberger
                                  This research program was under-
                                taken to improve the scoring of the
                                transformation by chemical carcino-
                                gens of C3H/10T1/2 mouse embryo
                                fibroblasts.
                                  1) A probabilistic view of the trans-
                                    formed focus formation in these
                                    cells induced by methylcholan-
                                    threne (MCA) treatment has been
                                    formulated and validated. The
                                    authors define  PI as the proba-
                                    bility that a cell will be activated
                                    by carcinogen  treatment, P2 as
                                    the probability per cell generation
                                    that an activated cell  will be
                                    transformed, and P3 as the prob-
                                    ability per cell generation that an
                                    activated cell will be deactivated.
                                   The equation derived is

                                log(F/N) = log [2p,p2 (1 -p3)/2(1 -p3)-1 ] +
                                          nlog (1-p3),

                                where F = mean no. of foci per dish; N =
                                no. of cells at confluence; and n = no.
                                of cell generations to confluence.
                                 2) 5-Azacytidine induces differen-
                                   tiation  of C3H/10T1/2 cells
                                   into both  muscle cells and adi-
                                   pocytes. Although phorbol-ester
                                   related tumor promoters inhibit
                                   muscle cell formation, this is not
                                   affected by inhibitors of tumor
                                   promotion; moreover, other
                                   classes of tumor promoters do
                                   not inhibit this differentiation.
                                   Effects  of promoters on adipo-
                                   cyte formation were inconsistent.
                                    Hence, this assay cannot be used
                                    to screen for tumor promoters.
                                  3) The powerful tumor promoter,
                                    12-0-tetradecanoyl phorbol-13-
                                    acetate {TPA), produces tempo-
                                    rary and reversible rounding up
                                    of the cells and loosened adhe-
                                    sion to the substratum. Although
                                    TPA does not affect the growth
                                    rate of these cells in 10% fetal
                                    calf serum, it does stimulate their
                                    growth rate in 1 % fetal calf serum.
                                 4) A quantitative study of the "nat-
                                    ural history" of clones derived
                                    from various morphological types
                                    of transformed foci was carried
                                    out. All  tumorigenic  Type III
                                    clones formed  colonies in soft
                                    agarose, this growth efficiency
                                    increased with passage number,
                                    but only one Type II and  no Type I
                                    clones grew in soft agarose. Type
                                    I clones often progressed to Type
                                    II, and many Type II clones
                                    progressed to Type III upon fur-
                                    ther passaging.
                                 5) The cell-surface morphology was
                                    studied in the scanning electron
                                    microscope (SEM). Nontrans-
                                    formed cells had flat,  smooth
                                    surfaces. Transformed cells in
                                    logarithmic growth exhibited
                                    rough surfaces with ruffles, blebs,
                                    and microvilli; however, the sur-
                                   faces of transformed cells post
                                   confluence became smooth.
                                    "Mini-foci" of rough-surfaced

-------
     cells were visible within five days
     after MCA treatment.
  6) Preliminary experiments revealed
     that monoclonal antibodies com-
     mon to transformed clones, which
     are probably against oncofetal
     antigens,  can be prepared, and
     should be useful for scoring trans-
     formation.
  7) Mouse peritoneal macrophages
     activated by BCG treatment se-
     lectively kill chemically trans-
     formed, but not nontransformed
     C3H/10T1/2 cells.
  8) By mutagenesis of atumorigenic
     transformed clone of these cells,
     followed by selection post-
     confluence at 39.5° with FUdR
     and extensive cloning, six mu-
     tants temperature-sensitive for
     transformed phenotypes were
     isolated and characterized.
  This Project  Summary was devel-
oped by EPA's Health Effects Research
Laboratory, Research Triangle Park.
NC, to announce key findings of the
research project that is fully docu-
mented in a separate report of the
same title (see Project Report ordering
information at back).


Introduction
  It is now generally accepted that 70-
90% of human cancers are environ-
mentally caused. Since our environment
contains  over 500,000 naturally oc-
curring and manmade chemicals that
have not been tested for carcinogenicity,
and since it costs about $500,000 per
compound for a conventional large
scale carcinogenesis test in hundreds of
rats  and mice  kept throughout  their
lifespan, it would cost $250,000,000,000
to test  them all  conventionally.  This is
clearly prohibitive. Thus, the inescapable
conclusion is that much  quicker and
less expensive methods of prescreening
must be developed and validated.

  The widely heralded Ames test ap-
pears to be highly promising as such a
prescreen. There is an impressive cor-
relation between the carcinogenic ac-
tivies  of 300 chemicals and their
microsome-activated mutagenesis  to
tester strains of Salmonella typhimurium.
However, the correlation is not perfect,
there is yet no conclusive proof that
carcinogenesis results from a somatic
mutation, and (trite as is sounds) bacte-
ria do not get cancer. Hence, it would be
folly to rely solely on one prescreening
system.
  At the present time, several systems
have been developed for obtaining
quantitative  data  on the oncogenic
transformation of cultured cells by
chemical carcinogens.  It seems clear
that such systems, although more com-
plicated and tedious than a bacterial
mutagenesis assay, may be more rele-
vant as prescreens for carcinogenic
activities. They also provide valuable
test materials for studying the cellular
and molecular mechanisms of chemical
carcinogenesis; such information will
be of practical value in providing means
to.prevent human cancer.

  In this study, a system was developed
for studying chemical oncogenesis in
vitro with the C3H/10T1/2 mouse
embryo fibroblasts. However, before
this system can be validated as a poten-
tial prescreen  by testing in it a larger
number of carcinogenic  and noncarcin-
ogenic chemicals, additional research
must be done to perfect  its quantitative
application.
  The perfection and validation of this
system that determines and quantitates
oncogenic transformation will produce
the following benefits:
  1) The  availability of  a reliable pre-
     screen for environmental carcino-
     gens (or mixtures thereof), which
     is one of the highest priorities in
     environmental surveillance.
  2) Such a pre-screen can be widely
     applied to test large numbers of
     samples  (pure compounds and
     mixtures) of environmental pol-
     lutants for their carcinogenic ac-
     tivity.
  3) The determination of the oncogenic
     transformation of cultured animal
     cells is much  more relevant to
     human carcinogenesis than mea-
     suring mutagenesis in bacteria or
     other biological or biochemical
     parameters.
  4) The cost, space, and manpower
     requirements to test individual
     samples would be expected to be
     less than  1 % of those necessary to
     carry out adequate tests  for car-
     cinogenesis in living rodents.
  5) In addition to surveillance of gen-
     eral environmental samples for
     carcinogenic activity, this system
     could be used to monitor the
     changes in carcinogenic activities
     of specifically collected specimens.
  6) The perfection of this pre-screen
     will  also provide important funda-
     mental information on the mecha-
     nisms of chemical  carcinogenesis
     that, if intelligently applied, might
     lead to prevention of many types of
     human cancer.
  7) Such a surveillance could lead to
     major  steps in the  abatement of
     carcinogenic pollutants.

Results and Discussion

Probabilistic Theory of
Transformed Focus Formation
  One of the original aims of the project
was to apply to C3H/10T1/2 cells the
transformation of single individual cells
in dishes or microtiter plates, such as
had been previously done with mouse
prostate fibroblasts. It soon became
evident, however, that the effects of cell
density on transformation  were so
major as to obscure the very meaning of
the concept of transformation frequency.
This was reinforced by early reconstruc-
tion experiments in which focus forma-
tion was measured after mixing of
known  numbers of nontransformed and
transformed cells. Here it became evi-
dent that the numbers of foci in  the
dishes  did not follow Poisson distribu-
tions, and that there was considerable
migration of transformed cells to form
satellite foci. Moreover, we found that
the  use of microtiter plates for trans-
formation experiments, even with single
cells, was  not suitable because of
variations in the background and indis-
tinctness of the transformed  foci that
precluded their classification as Type I,
II, or III, as originally defined and studied.
It soon  became clear that the enormous
amount of time-consuming labor that
went into the preparation and inspection
of the dishes containing single cells, as
well as the enormous number of dishes
that would be required to obtain statisti-
cally significant results, precluded this
approach to improved quantitation and
scoring of this bioassay system. These
complexities led to a theoretical and
experimental examination  of  a proba-
bilistic theory of transformed focus
formation, which should have major
impact on the field.

Quantitative Study of the
Properties of Cells Derived
from  Various Types  of Foci
  In this study, a rigorous investigation
was made of various of the transformed
phenotypes in a series of cell lines
derived as defined below, in order to
relate the "natural history" and evolu-
tion of these cultures to the phenomenon
of tumor progression. In a variety of cell

-------
culture systems an extremely tight
correlation has been observed between
the ability of a transformed cell to grow
when cultured  in semi-solid media
(anchorage independence for growth)
and its ability to grow as a tumor in vivo.
At the inception of this study, very little
was known  about the relationship be-
tween C3H/10T1/2 transformation
and  anchorage  independent- growth.
The  acute need for cell  culture cor-
relates  with in vivo  tumorigenicity
prompted the initiation of this work. The
ability of  cells to grow in semi-solid
medium was assayed following a modi-
fication of  the  basic  procedures of
Macpherson for soft agar  culture.
  Agarose was found to be superior for
the culturing of 58MCA Cl 16 cells,
permitting the formation of large colo-
nies with  a  high plating efficiency. An
agarose overlay concentration of 0.25%
was found to be optimal. Higher overlay
concentrations reduced colony sizes.
Lower agarose concentrations were too
dilute and colonies were observed to
grow, migrate, fragment and fuse.
  Once the  optimal conditions for soft
agarose culture  had been determined,
C3H/10T1/2 Cl 8  and a number of
transformed  variants were assayed for
anchorage independence of growth. All
eight tumorigenic cell lines tested grew
in soft agarose culture. In general, all
transformed  cell lines fell into one of
two classes  with respect  to the size of
the colonies formed in soft agarose
culture.  Most of  the cell lines grew to
form only  small colonies (25-200 cells)
but some  cell lines grew  to form very
large colonies containing 1000 or more
cells.
  The ability of cells to grow as tumors
was assayed in  syngeneic C3H mice.
Mice were X-irradiated (450r) 24 hours
prior to the injection of cells. Cells
(2x106) were then inoculated subcuta-
neously and the animals examined
weekly for six months for  the presence
of tumors.
  Of the five nontumorigenic cell lines
tested here, three (including C3H/1OT1 /
2) showed no, or very poor, capacity for
growth in soft agarose.
  The ability of a cell line to grow in soft
agarose increased as a function of the
number of passages it is maintained in
culture, since the plating efficiency and
colony size  of cells grown in agarose
increased with passage  number. The
results with  OMBA Cl III are particularly
noteworthy. These cells  were nontu-
morigenic when tested at passage 7, but
 were tumorigenic when tested at pas-
 sage 15. The acquisition of tu morigenicity
 in these cells appears to be accompanied
 by an increase in the ability to grow in
 soft agarose.
   The fact that none of these  early
 transformed cell lines were tumorigenic
 at early passages, whereas 58 MCA Cl
 16 was highly tumorigenic, suggests
 that oncogenic transformation occurs in
 several steps  or that  the  transformed
 cell lines  are  too strongly antigenic to
 induce tumors- in C3H mice that were
 immunosuppressed by 450 radX-irradi-
 ation. The feasibility of using intracranial
 injections  or nude mice for tumorgenicity
 studies is now under study.

 Morphology of Nontransformed
 and Transformed Cells in the
 Scanning Electron Microscope
 (SEM)
   Subconfluent cultures of C3H/10T1 /2
 cells  taken  at various times following
 treatment for  24 hr with 1.0 Aig/ml of
 MCA were examined  in the  SEM. The
 surface morphology of untreated cells is
 flat and featureless.
   This study recently discovered that
 these carcinogen-treated cultures form
 a new transformation parameter, "mini-
 foci," which are seen also in cultures
 derived from Type II and Type III foci.
 Mini-foci are groups of cells growing on
 top of each other in a criss-cross fashion
 and are detected under subconfluent
 culture conditions. They have  been
 detected in  MCA exposed cultures as
 early  as four and seven days following
 treatment. Similarly grouped cells have
 also been found in 7-day cultures treated
 with MCA (0.1 fjg/m\, 24  hr) alone or
 MCA  (0.1  Aig/ml, 24 hr) plus TPA (0.1
 //g/ml, four days after MCA treatment)
 but apparently  in much lower frequency.
 Mini-foci  have not been  detected  in
 control-cultures.
  SEM  studies of  carcinogen treated
 confluent  cultures proved uninteresting
 and did not reveal differences in cell
 surface morphology that could be defi-
 nitely identified as similar to or charac-
 teristic of transformed (Cl 16) cells. This
 was true  even with cells in  foci-like
 areas identifiable by light  microscopy.
 Because of these rather disappointing
 results, the author proposed to reexam-
 ine certain assumptions and start with
cells from foci of transformed  cells
detectable by light microscopy. Sublines
of cells isolated from the three different
types of foci - Type I, Type II and Type III
were  studied. A "Type 0" subline,
 isolated from the "flat" areas between
 foci of cells in carcinogen  exposed
 cultures, was also available. These, as
 well as controls (subline from acetone
 treated cells) were coded and processed
 for SEM  examination. The  cultures
 were seeded as usual (5000  cells per
 dish) and fixed for SEM at 4, 5 (subcon-
 fluent), 8 (confluent), and 14 days. The
 identity of each sample was checked
 only after completion of SEM examina-
 tion.
  SEM studies of these samples yielded
 encouraging results with  subconfluent
 (4,  5 days) cultures. Cells with altered
 morphology and distinguishable from
 controls were easily seen in Type III and
 Type II cultures. These cultures had cells
 that often occurred in groups and tended
 to overlap each  other in  a criss-cross
 fashion. These "mini-foci" were taken
 to be significant in view of their similarity
 to the foci seen in the light microscope,
 and are considered to be  diagnostic of
 transformed cells. Additionally, many
 cells in these early cultures showed a
 profusion of microvilli and blebs on their
 surfaces, and presented a morphology
 similar to Cl 16 or other oncogenic
 transformed cell populations. Type I
 cells were mostly non-overlapping and
 had fewer altered cells with microvilli
 and blebs,  but their sparseness made
 scoring of these cultures as transformed
 difficult and equivocal. Type 0 cultures
 were similarly equivocal. Control, ace-
 tone treated cultures at similar subcon-
 fluency showed  little or no detectable
 criss-cross cells, but  contained  cells
 with microvilli and ruffles. These cells at
 the  relatively low (less than 400x)
 magnifications commonly used could
 not be  distinguished as being  different
 from those seen in the Type 0 and Type I
 cultures. Thus, distinctions between
Type I,  Type 0, and A (acetone) controls
 are equivocal and subjective. Experience
 suggests that quantitative analyses
should be attempted in the future to
 make clear the distinctions, if any,
among these cultures.

  In other experiments, cells from Cl 16
 (MCA-transfprmed, tumorigenic)  were
 examined after growth  on  glass or
 plastic surfaces under confluent and
 subconfluent conditions. The results of
 this study showed easily detectable
 cells with transformed morphologies in
 Cl 16  cultures. Subconfluent cultures
 were best for detection of the trans-
 formed cells. Cl 16 cells in comparison
 to control cells appeared less tightly
 adherent to the growing surface (more

-------
rounded). Cell surfaces often contained
blebs and microvilli. Microvillar distri-
bution and  size often appear to be
heterogeneous. Cell criss-crossing was
also noted. This overall morphology was
maintained even in five-day-old cultures,
a time at which  control cultures are
well-spread,  actively growing and often
nearly confluent.  Confluent Cl 16 cul-
tures were much less remarkable in
appearance,  had many fewer cells with
large  blebs or microvilli, and generally
were difficult to distinguish from control
10T1/2 cells. Nonetheless, closer ex-
amination showed subtle changes in
cell-cell associations and cell shape.
  In summary, the experiments done so
far permit the conclusion that trans-
formed cells  are recognizable by scan-
ning  electron microscopy at early times
(within one week of carcinogen expo-
sure) in terms of changes in cell surface
morphology,  and/or cell shape and/or
cell to cell  association (close, tight
adhesion vs.  loose contact; criss-cross,
piled vs. parallel oriented, contact-
inhibited). Secondly, the expression of
these changes is dependent upon cul-
ture  conditions such  as cell density.
Thirdly,  it was noted that treatment of
C3H/10T1/2 cells with two different
chemical carcinogens can result in dis-
similar but transformed phenotypes.

Development of Monoclonal
Antibodies to Oncofetal
Antigens on Transformed Cells
  For the prototype experiments, two
oncogenically transformed clones were
chosen that had previously been shown
to exhibit the oncofetal antigen: MCA Cl
15 and DMBA Cl 2. C3H mice were
immunized three times at weekly inter-
vals  with 5x105 DMBA Cl  2  cells by
intraperitoneal injections and were bled
three days after the last immunization.
The binding capacity of the antibodies to
the transformed  cells was determined
by the binding of protein A. This protein,
which is a single polypeptide isolated
from  the cell wall of Staphylococcus
aureus, has  an extraordinary affinity of
binding to the Fc region of the immuno-
globulin IgG. Thus, the assay measures
the amount  of protein A (labeled with
125I) that binds to the Fc portion of the
antibody, which in turn binds to the
surface antigen of the intact cell through
the Fab portion  of the antibody. The
transformed  cells (1 xl O5) were plated in
Falcon  96 well microtiter plates and
allowed to attach for 12 hours. They
were then washed three times  with
Basal Medium Eagle's (BME) with 1%
bovine serum albumin. The cells were
then treated for 30 minutes at4°C with
the mouse antiserum or various dilutions
thereof in BME. The  cells were again
washed 3 times with BME and incubated
for 1 hr at room temperature with 105
cpm  of 1Z5l-protein A (Pharmacia) radio-
iodinated with chloramine  T (86) in
phosphate buffered saline (PBS), and
then washed three times with PBS. The
wells of the microtiter plate were sawed
out,  placed in liquid scintillation vials,
and  the bound 125I was counted. The
antiserum obtained from OMBA Cl 2
immunized mice bound to those cells
and to MCA Cl 15 cells to approximately
the same extent and to a significantly
higher extent than to the non-immune
serum control  at dilutions of 1:5. This
similarity in extents of binding suggests
that  the antibody bound to a common
cell-surface antigen on both transformed
cells.
  There was no significant binding of
nontransformed C3H/10T1 /2 Cl 8 cells
to antisera prepared against those cells
or to the antiserum prepared against the
transformed DMBA Cl 2 cells. Moreover,
the transformed DMBA Cl 2 cells reacted
with the antiserum directed against the
same cells, but not with the antiserum
to the nontransformed cells. These two
experiments demonstrated that the
cells and assays used were sufficiently
selective and sensitive  to allow us to
proceed  to prepare monoclonal  anti-
bodies from hybridomas.
  C3H mice were immunized three
times once weekly with 5x106 DMBA Cl
2 transformed cells. Three days after the
last  immunization, spleen cells were
collected and fused with  a mouse
myeloma cell  line, P3 x 63/Ag8, that
lacks thymidine kinase using  polyethyl-
ene  glycol. After completion  of the cell
fusion and selection in HAT medium for
two weeks, the cells were then cultured
in regular medium. After the fourth
week in culture, the supernatants of the
hybridomas were added to target DMBA
Cl 2 cells plated in microtiter wells as
described previously and assayed by 125I
protein A binding. The wells were either
counted for 125I binding, or the pattern of
bound 125I was determined by autoradi-
ography at  -70°C. In a typical experi-
 ment, 4 out of  120 hybridoma wells
contained antibodies against the trans-
formed cells.  Experiments are now in
 progress to prepare pure clones of the
 hybridomas that secrete antibodies of
 the  desired properties.
Specific Killing of Transformed
Cells by Activated Peritoneal
Macrophages
  The first approach to this problem
involved setting up an assay for the
killing effect of activated peritoneal
macrophages. Since much of our work
involves determination of the reproduc-
tive capacity of cells by measuring their
plating efficiency,  and since this assay
has not been applied to  macrophage
killing, this method was used and
compared with the 125IUdR release
assay.
  The peritoneal macrophages  of C3H
mice were activated by injecting IP 1 ml
of BCG containing 2 x 107 live organisms.
Nine days later, the mice were injected
IP with 2 ml of thioglycollate  5 days
before harvesting the macrophages.
After harvesting, the cells were counted
and plated in 100 mm dishes (2x106/
dish) with 10 ml of Basal Medium Eagle
(BME)  + 10% fetal  calf serum (PCS).
After one hour's incubation, the medium
was aspirated out; the adherent cells
are practically all (90-95%) macrophages.
We then plated 5000 of our  test cells
with 10 ml of BME + 10% FCS and incu-
bated for 48 hr. At the end of this time all
the cells were scraped from  individual
dishes and replated, without  counting,
into 10 100 mm dishes with 10 ml of
medium in each. The dishes were incu-
bated for 10 days and fixed with  metha-
nol, stained with Giemsa and scored for
the development of colonies. The results
demonstrate that the activated  macro-
phages recognize the malignant DMBA
Cl 2 and MCA Cl 16 cells and kill them,
as shown by the decrease in number of
colonies. In contrast, the nontransformed
C3H/10T1/2 cells were not killed by
the macrophages and the number of
colonies was actually  increased as
compared to the dishes without macro-
phages. This is due to a feeder effect.
  An  exactly comparable experiment
was then set up with the nontrans-
formed C3H/10T1/2 Cl 8 cells, and
with acetone-treated and Types 0, I, II,
and Ill-derived cell lines at passage 9.
None of these cell lines at this passage
number grew significantly in soft agarose.
The activated macrophages again en-
hanced the plating efficiency of the
C3H/1OT1 /2 Cl 8 cells, but produced no
significant effect  on the reproductive
capacity of the others except for a
marginal killing effect on the Type III cell
line.
  Dr. Michael Fisher of the  Frederick
Cancer Center  has  performed  on our

-------
 ells a newly developed  microassay,
 tiich is carried out in 96-well microtiter
 lates. Log phase target cells are pre-
 abeled for 24 hours with 0.2 //Ci/ml of
 25IUdR washed three times, and trypsin-
 zed and counted. Mouse peritoneal
 tacrophages were activated in culture
 /ith macrophage activating factor (MAP)
 78) for  24 hours.  Then 105 viable
 trypan blue) macrophages (MP) are
 dded to  each microtiter well. After 45
 Tin the macrophages were washed
 hree  times to remove nonadherent
 ells, and 5 x103 target cells were added
 o each well so that the ratio of macro-
 ihages to target cells added was 20:1.
 tfter one day, the cells were washed to
 emove nonadherent cells, and incuba-
 ion was  carried on for three additional
 'ays when the cells were washed three
 imes  and incubated for one hour with
 ):1  N NaOH, and the radioactivity of the
 JaOH  lysate was determined in a gamma
 :ounter.  In all experiments, controls
 vere run in which the target cells were
 ncubated with nonactivated peritoneal
 nacrophages. The target cells were
 ;ent to Dr.  Fisher at the 9th passage,
 ind were tested  by him  at the 14th
 >assage.
  In these experiments there was no
 :ytolysis produced by the nonactivated
 nacrophages of any of the cell lines, or
 >y the activated macrophages on the
 lontransformed C3H/10T1/2 Cl  8,
 icetone-treated, or Type I cells. How-
 iver, there was significant lysis of the
 Vpes  II and III cells, as well as of the
 >ncogenically transformed MCA Cl 16
 :ells.  It  is not known whether the
 differences in  results between these
 sxperiments and the ones done by
 jlating efficiency are due to the dif-
 erence in the assay, the difference in
 he  method of activation of the macro-
 phages, or the difference in the passage
 lumber of the Types II and 111 cells. It is
 :lear,  however, that  the micro 125IUdR
 assay  is  quicker, easier, requires less
 sells and media, and is more accurate
 nan the plating efficiency assay. Hence,
all future experiments will be done by
 he  micro radioactivity assay.


 Conclusions
  All work supported by this grant was
aimed at improving the scoring, and
making it more rapid and quantitative, of
the  C3H/10T1/2 mouse embryo fibro-
blast system for oncogenic transforma-
tion and  its initiation and promotion.
The following conclusions have been
drawn:
  1 ) A probabilistic view of transformed
     focus formation in these cells in-
     duced by methylcholanthrene
     (MCA) treatment has been formu-
     lated and validated. We define Pi
     as the probability that a cell will be
     activated by carcinogen treatment,
     P2 as the probability per cell gen-
     eration that an activated cell will
     be transformed, and Pa  as the
     probability per cell generation that
     an activated cell will be deactivated.
     The equation derived is
log(F/N) = log [2Plp8
             nlog (1
where F = mean no. of foci per dish; N =
no. of cells at confluence; and n = no. of
cell generations to confluence.
  2) 5-Azacytidine induces differentia-
     tion of C3H/10T1/2 cells into
     both muscle cells and adipocytes.
     Although phorbol-ester related
     tumor promoters inhibit muscle
     cell formation, this is not  affected
     by  inhibitors of tumor promotion;
     moreover, other classes of tumor
     promoters do not inhibit  this dif-
     ferentiation. Effects of promoters
     on  adipocyte formation were in-
     consistent. Hence, this assay can-
     not be  used to screen for tumor
     promoters.
  3) The powerful tumor promoter, 1 2-
     0-tetradecanoyl  phorbol-13-ace-
     tate (TPA), produces temporary
     and reversible rounding up of the
     cells and loosened adhesion to the
     substratum. Although TPA does
     not affect the growth rate  of these
     cells in 10% fetal calf serum, it
     does stimulate their growth rate in
     1% fetal calf serum.
  4) A quantitative study of the "nat-
     ural history"  of  clones  derived
     from various morphological types
     of transformed foci was carried
     out. All tumorigenic Type III clones
     formed colonies in soft agarose,
     this growth efficiency increased
     with passage number, but only
     one Type II and no Type  I clones
     grew in soft agarose. Type I clones
     often progressed to Type II, and
     many Type II clones progressed to
     Type III upon further passaging.
  5) The cell-surface morphology was
     studied  in the scanning electron
     microscope (SEM). Nontra'ns-
     formed cells had flat, smooth sur-
     faces. Transformed cells  in loga-
     rithmic growth exhibited rough
     surfaces with  ruffles, blebs, and
     microvilli; however, the surfaces
     of transformed cells post con-
     fluence became smooth. "Mini-
     foci" of rough-surfaced cells were
     visible within five days after MCA
     treatment.
  6) Preliminary experiments revealed
     that  monoclonal antibodies com-
     mon  to transformed clones, which
     are probably against oncofetal
     antigens, can  be  prepared, and
     should be useful for scoring trans-
     formation.
  7) Mouse peritoneal  macrophages
     activated by BCG treatment se-
     lectively kill  chemically trans-
     formed, but not nontransformed
     C3H/10T1/2 cells.
  8) By mutagenesis of a tumorigenic
     transformed clone of  these cells,
     followed by selection post-con-
     fluence  at 39.5° with FUdR and
     extensive cloning, six mutants
     temperature-sensitive for trans-
     formed phenotypes were isolated
     and characterized.
  Several  of the initial objectives have
been realized, and sufficiently promising
preliminary data have been collected to
make it highly likely that continuation of
this research will lead to  the accom-
plishment  of all the objectives.

Recommendations
  The numbers of these recommenda-
tions pertain to the numbers of the
conclusions previously stated.
  1) The probabilistic view of trans-
     formed focus  formation of C3H/
     10T1/2  cells  following chemical
     carcinogen treatment has been
     derived and validated. This is
     expected to have a major impact
     on the quantisation and interpre-
     tation of transformation  in this
     transformation system that is now
     widely used throughout the world.
     This research should be continued.
  2) The effects of tumor promoters on
     the 5-azacytidine-induceddiffer-
     entiation of C3H/10T1/2 cells
     into muscle cells and adipocytes
     may be useful in establishing the
     mechanism of action of phorbol
     ester-related tumor promoters.
     However, inconsistent results pre-
     clude this from being used as a
     short-term test for tumor promot-
     ers.  Hence, this approach has
     been discontinued.
  3) Since the transient rounding-up of
     cells following TPA treatment does
     not occur on repeated treatments,
     which are required for promotion

-------
     of transformation, this effect is
     unlikely to  be involved in tumor
     promotion. The growth-stimulating
     effect of TPA in 1 % fetal calf serum,
     seems  unlikely  to be  involved in
     the  mechanism  of promotion  be-
     cause promotion experiments  are
     carried out in 10% fetal calf serum
     in which no growth stimulation
     was observed. Hence, these  ap-
     proaches are being discontinued.
  4) The study of the "natural history"
     of transformed foci has been com-
     plicated, and further studies  are
     required to fully assess the signifi-
     cance of the various transformed
     phenotypes.
  5) The  appearance  of "mini-foci,"
     detectable in the scanning electron
     microscope (SEM) only a few days
     after chemical carcinogen treat-
     ment, is a highly promising lead to
     improve  the rapidity of scoring.
     This led  to  an application to  the
     EPA for continuation of this  re-
     search, which is currently funded
     as EPA Grant No. R-808309, and
     the  research continues.
  6) The preliminary finding that
     monoclonal antibodies can be pre-
     pared  that react with various
     transformed clones, is extremely
     promising. The antibodies can be
     radioiodinated and rapid, objective,
     and highly sensitive radioimmuno-
     assay can be developed for trans-
     formation. Alternatively, the anti-
     body can be labeled with fluores-
     cence and transformed cells can
     be visualized in a fluorescence
     microscope and can be separated
     in a fluorescence activated cell
     sorter. This is also currently funded
     on EPA Grant No. R-808309, and
     the  research continues.
  7) Although activated mouse perito-
     neal macrophages selectively  kill
     chemically transformed cells, it is
     highly unlikely that this test can be
     made  sufficiently  sensitive to be
     used as a primary means of scor-
     ing  for  transformation.
  The successes of  the approaches
described in 1, 5, and 6, together with
interesting  data collected from the
research described in 2, 3, 4, and 7
indicate that the results obtained on this
grant, R-805-208, were very successful.
Charles Heidelberger is with the University of Southern California Cancer
  Center, LosAngeles, CA 90031.
Michael D.  Waters is the EPA Project Officer (see below).
The complete report,  entitled "Irriproved Scoring of Chemical Transformation of
  C3H/WT1/2 Cells," (Order No.  PB 81-209 686; Cost: $6.50, subject to
  change) will be available only from:
        National  Technical Information Service
        5285 Port Royal Road
        Springfield.  VA 22161
        Telephone: 703-487-4650
The EPA Project Officer can be contacted at:
        Health Effects Research Laboratory
        U.S. Environmental Protection Agency
        Research Triangle Park, NC 27711
                                                                            tUS GOVERNMENT PRINTING OFFICE 1981 -757-012/7238

-------
United States
Environmental Protection
Agency
Center for Environmental Research
Information
Cincinnati OH 45268
Postage and
Fees Paid
Environmental
Protection
Agency
EPA 335
Official Business
Penalty for Private Use $300
         i'o    0000 32 J
         u  s  t>viH  tMurt.cn
                        - ^  * i . » j J1
          230
                      ii.

-------